The microcarriers market is projected to reach USD 3.3 billion by 2028 from an estimated USD 2.0 billion in 2023, at a CAGR of 10.0% during the forecast period. The major factors driving the growth of this microcarriers market include increasing technological advancements in biopharmaceutical field, growing fundings for research and development, and rising demand for cell culture systems.
The global microcarriers market is competitive with top players such as Merck KGaA (Germany), Danaher (US), Thermo Fisher Scientific Inc. (US), and FUJIFILM Holdings Corporation (Japan). The market players have adopted various strategies such as acquisitions, new product/service launches, collaborations, agreements, and geographical expansions to strengthen their position in the global microcarriers market.
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific Inc. (US)
Thermo Fisher Scientific is a leading manufacturer of laboratory equipment, analytical instruments, consumables, software, and reagents. The company aims to build strong customer base through strategic approaches such as acquisitions, partnerships, collaborations, and expansions in emerging markets like India, China, and South Korea. The company has a strong geographic presence across 180 countries. Thermo Fisher Scientific continues to expand operating facilities to meet the customer requirements. For instance, in September 2021, Thermo Fisher Scientific expanded its manufacturing capabilities by establishing a new facility in Nashville dedicated to the production of single-use technologies (SUT) products. The facility is one of the world's largest SUT manufacturing sites and will more than double the company's SUT manufacturing capacity in support of its biopharma customers.
Danaher is one of the leading players in the microcarriers market. The company manufactures medical and industrial products. The company has a strong global presence across 60 countries with 261 operating facilities. Danaher has adopted strategic approaches including new product launches, acquisitions, collaborations, and partnerships to strengthen its customer base. For instance, in May 2023, Cytiva acquired CVEC Pharmaceuticals GmbH to strengthen the customer base of Cytiva in biopharmaceutical market.
Sartorius AG (Germany)
Sartorius AG is a global company specializing in providing cutting-edge solutions for the biopharmaceutical industry and laboratories. It has employed a combination of organic and inorganic strategies, including acquisitions, product launches, and expansions, as means to bolster its position in the market. One notable move was the April 2020 acquisition of Danaher Corporation's portfolio, specifically from the Danaher life science division, which encompassed microcarrier technology. This acquisition significantly broadened Sartorius AG's range of microcarriers, incorporating varieties coated with animal proteins as well as animal product-free options designed for cell line attachment and the growth of anchorage-dependent cells.
Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Culture Vessel, Filtration), Consumables (Media, Reagent), Beads (Collagen, Cationic), Application (Vaccine, Cell & Gene Therapy), End User - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE